Histogenics (HSGX) Reaches $2.78 After 7.00% Down Move; Pinebridge Investments LP Has Trimmed Williams Cos Del Com (WMB) Stake By $10.02 Million

January 14, 2018 - By Richard Conner

The stock of Histogenics Corporation (NASDAQ:HSGX) is a huge mover today! The stock decreased 4.79% or $0.14 during the last trading session, reaching $2.78. About 506,761 shares traded or 315.76% up from the average. Histogenics Corporation (NASDAQ:HSGX) has declined 7.61% since January 14, 2017 and is downtrending. It has underperformed by 24.31% the S&P500.The move comes after 7 months negative chart setup for the $66.92 million company. It was reported on Jan, 14 by Barchart.com. We have $2.59 PT which if reached, will make NASDAQ:HSGX worth $4.68 million less.

Pinebridge Investments Lp decreased Williams Cos Inc Del Com (WMB) stake by 87.14% reported in 2017Q3 SEC filing. Pinebridge Investments Lp sold 334,089 shares as Williams Cos Inc Del Com (WMB)’s stock rose 7.09%. The Pinebridge Investments Lp holds 49,291 shares with $1.48M value, down from 383,380 last quarter. Williams Cos Inc Del Com now has $27.46B valuation. The stock increased 0.33% or $0.11 during the last trading session, reaching $33.21. About 4.37 million shares traded. The Williams Companies, Inc. (NYSE:WMB) has risen 40.20% since January 14, 2017 and is uptrending. It has outperformed by 23.50% the S&P500.

Investors sentiment increased to 1.19 in 2017 Q3. Its up 0.13, from 1.06 in 2017Q2. It improved, as 40 investors sold WMB shares while 203 reduced holdings. 66 funds opened positions while 223 raised stakes. 687.46 million shares or 1.13% less from 695.32 million shares in 2017Q2 were reported. Asset Inc owns 75,408 shares. Citigroup, a New York-based fund reported 1.40 million shares. Geode Capital Management Ltd Liability Com owns 0.1% invested in The Williams Companies, Inc. (NYSE:WMB) for 8.61M shares. 509,104 are owned by Vaughan David Investments Inc Il. Sun Life Fincl stated it has 6,106 shares or 0.02% of all its holdings. Eaton Vance Management owns 111,996 shares. Voya Investment Management Ltd Liability Corporation holds 0.03% in The Williams Companies, Inc. (NYSE:WMB) or 521,528 shares. Barrett Asset Mngmt Ltd Liability Co reported 2,500 shares. Barclays Public Ltd Co invested in 1.08 million shares or 0.03% of the stock. Harvest Fund Llc accumulated 11.28M shares or 3.51% of the stock. Ingalls Snyder Ltd Com has 3.33% invested in The Williams Companies, Inc. (NYSE:WMB). Nj State Employees Deferred Compensation Plan holds 0.19% or 35,000 shares. Bokf Na accumulated 304,437 shares. Bedrijfstakpensioenfonds Voor De Media Pno owns 64,747 shares. Nationwide Fund Advisors invested in 0.03% or 232,736 shares.

Since August 8, 2017, it had 0 insider buys, and 3 selling transactions for $8.61 million activity. 9,913 shares were sold by Ewing Robyn L, worth $297,250 on Wednesday, September 27. Shares for $61,310 were sold by Timmermans Ted T. 272,088 The Williams Companies, Inc. (NYSE:WMB) shares with value of $8.25 million were sold by CHAPPEL DONALD R.

Analysts await The Williams Companies, Inc. (NYSE:WMB) to report earnings on February, 21. They expect $0.20 earnings per share, up 17.65% or $0.03 from last year’s $0.17 per share. WMB’s profit will be $165.35M for 41.51 P/E if the $0.20 EPS becomes a reality. After $0.15 actual earnings per share reported by The Williams Companies, Inc. for the previous quarter, Wall Street now forecasts 33.33% EPS growth.

Among 18 analysts covering Williams Companies Inc. (NYSE:WMB), 13 have Buy rating, 0 Sell and 5 Hold. Therefore 72% are positive. Williams Companies Inc. had 47 analyst reports since July 23, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, April 3 by Jefferies. The company was maintained on Monday, June 5 by RBC Capital Markets. Raymond James downgraded the shares of WMB in report on Friday, May 6 to “Market Perform” rating. The stock has “Overweight” rating by Morgan Stanley on Friday, November 17. The stock of The Williams Companies, Inc. (NYSE:WMB) earned “Buy” rating by Jefferies on Monday, January 23. Jefferies maintained the shares of WMB in report on Wednesday, August 2 with “Buy” rating. Argus Research maintained it with “Buy” rating and $49.98 target in Wednesday, August 12 report. The firm has “Buy” rating given on Monday, October 16 by Jefferies. The stock has “Buy” rating by Citigroup on Friday, April 7. The firm earned “Hold” rating on Thursday, July 23 by Jefferies.

Pinebridge Investments Lp increased Hasbro Inc Com (NASDAQ:HAS) stake by 6,164 shares to 12,205 valued at $1.19 million in 2017Q3. It also upped Yum Brands Inc Com (NYSE:YUM) stake by 7,050 shares and now owns 8,723 shares. Omnicom Group Inc Com (NYSE:OMC) was raised too.

Analysts await Histogenics Corporation (NASDAQ:HSGX) to report earnings on March, 15. They expect $-0.22 EPS, up 86.25% or $1.38 from last year’s $-1.6 per share. After $-0.23 actual EPS reported by Histogenics Corporation for the previous quarter, Wall Street now forecasts -4.35% EPS growth.

Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace in the United States. The company has market cap of $66.92 million. The firm offers NeoCart, a tissue implant, which is in Phase III clinical trial to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. It currently has negative earnings. It has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans.

Among 6 analysts covering Histogenics Corp (NASDAQ:HSGX), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Histogenics Corp had 16 analyst reports since August 27, 2015 according to SRatingsIntel. The firm has “Buy” rating by Canaccord Genuity given on Thursday, December 21. The stock of Histogenics Corporation (NASDAQ:HSGX) has “Buy” rating given on Friday, August 12 by BTIG Research. Canaccord Genuity maintained it with “Buy” rating and $4.0 target in Monday, October 16 report. The firm has “Market Perform” rating given on Wednesday, September 7 by William Blair. H.C. Wainwright maintained Histogenics Corporation (NASDAQ:HSGX) rating on Wednesday, December 27. H.C. Wainwright has “Buy” rating and $3.5 target. Needham maintained Histogenics Corporation (NASDAQ:HSGX) on Friday, November 13 with “Buy” rating. The stock of Histogenics Corporation (NASDAQ:HSGX) has “Neutral” rating given on Friday, November 13 by BTIG Research. The firm has “Buy” rating by H.C. Wainwright given on Monday, December 19. On Friday, November 13 the stock rating was maintained by Canaccord Genuity with “Buy”. The firm has “Hold” rating by Zacks given on Thursday, August 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: